Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-EN Version v17-EN
Language English English
Date Updated 2019-05-04 2019-05-03
Drug Identification Number 02385392 02385392
Brand name DIAZEPAM INJECTION USP DIAZEPAM INJECTION USP
Common or Proper name DIAZEPAM INJECTION USP DIAZEPAM INJECTION USP
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients DIAZEPAM DIAZEPAM
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 2 mL 2 mL
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-09-03 2018-09-03
Estimated end date
Actual end date 2019-05-03 2019-05-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments